CINECA IRIS Institutional Research Information System

DI MUNNO, OMBRETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.946
EU - Europa 2.198
AS - Asia 857
AF - Africa 215
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 7.228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.766
IT - Italia 791
CN - Cina 480
SE - Svezia 364
BG - Bulgaria 247
UA - Ucraina 236
DE - Germania 187
CA - Canada 179
CH - Svizzera 121
VN - Vietnam 101
FI - Finlandia 99
NG - Nigeria 94
SN - Senegal 94
SG - Singapore 89
TR - Turchia 88
GB - Regno Unito 59
IN - India 51
HK - Hong Kong 36
AT - Austria 31
CI - Costa d'Avorio 25
RU - Federazione Russa 16
BE - Belgio 14
FR - Francia 13
IR - Iran 8
AU - Australia 6
SI - Slovenia 6
IE - Irlanda 5
TW - Taiwan 4
EU - Europa 3
RO - Romania 3
BR - Brasile 2
LT - Lituania 2
NL - Olanda 2
CZ - Repubblica Ceca 1
GR - Grecia 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 7.228
Salva come PNG Salva come JPEG
Città #
Woodbridge 491
Chandler 430
Ann Arbor 414
Milan 407
Fairfield 333
Jacksonville 305
Sofia 246
Houston 225
Beijing 180
Ottawa 176
Ashburn 175
Wilmington 122
New York 119
Seattle 118
Bern 117
Cambridge 115
Nanjing 99
Dakar 94
Lagos 94
Lawrence 94
Princeton 94
Izmir 86
Medford 75
Jüchen 56
Nanchang 52
Des Moines 42
Dong Ket 40
Rome 40
Singapore 40
Dearborn 36
Hong Kong 33
Vienna 31
Abidjan 25
Pune 24
Bremen 23
Grafing 23
Ogden 22
Kunming 21
San Diego 21
Shenyang 21
Redwood City 19
Hebei 17
Brussels 14
Orange 14
Changsha 13
Boulder 11
Jiaxing 11
Serra 11
Auburn Hills 10
Hangzhou 10
Leipzig 10
Los Angeles 10
Norwalk 10
Tianjin 10
Frankfurt am Main 9
Hefei 9
Boardman 7
Ardabil 6
Florence 6
Jinan 6
Lanzhou 6
Mumbai 6
Padova 6
Changchun 5
Greifswald 5
San Mateo 5
Sydney 5
Carignano 4
Centuripe 4
Lecce 4
Monmouth Junction 4
Taipei 4
Verona 4
Washington 4
Detroit 3
Finale Ligure 3
Leawood 3
London 3
Ningbo 3
Pavia 3
Shanghai 3
Ypsilanti 3
Aversa 2
Costa Mesa 2
Council Bluffs 2
Dublin 2
Ebikon 2
Indiana 2
Livorno 2
Lucca 2
Pomigliano d'Arco 2
Torino 2
Toronto 2
Turin 2
Walnut 2
Acton 1
Amsterdam 1
Ancona 1
Angri 1
Athens 1
Totale 5.493
Salva come PNG Salva come JPEG
Nome #
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. 148
Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass 132
Vitamin D status and response to treatment in post-menopausal osteoporosis 132
Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis 130
Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients 129
Determinants of bone turnover markers in healthy premenopausal women 129
Quantitative ultrasound calcaneous measurements: normative data for the Italian population. the ESOPO study 125
Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. 119
Prevention of glucocorticoid-induced osteopenia: Effect of oral 25-hydroxyvitamin D and calcium 116
Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study 115
Determinants and Effects of Vitamin D Supplementation on Serum 25-Hydroxy-Vitamin D Levels in Patients with Rheumatoid Arthritis. 114
Prevenzione e trattamento dell’osteoporosi indotta dagli inibitori dell’aromatasi. 114
Lung function in essential mixed cryoglobulinemia: a short-term follow-up. 112
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. 112
Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study 110
The effect of age,weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study 109
Long-term prospective study of osteoporotic patients treated with percutaneous vertebroplasty after fragility fractures 109
Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability 104
Diagnostica strumentale: la densitometria ossea 103
Determinants of adherence to osteoporosis treatment in clinical practice 103
Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone 103
Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss 100
Lung involvement in essential mixed cryoglobulinemia. 99
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. 99
Deflazacort versus Methylprednisolone in Polymyalgia Rheumatica. Reply 99
A multicenter cross-sectional study on bone mineral density in rheumatoid arthritis 99
Efficacy of risedronate on clinical vertebral fractures within six months 98
Glucocorticoid-induced osteoporosis: 2013 update. 98
[Renal tubular acidosis in essential mixed cryoglobulinemia]. 97
Clinical equivalence between deflazacort oral drops and tablets in active rheumatoid arthritis 96
Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia 95
Optimizing Bisphosphonate Treatment Outcomes in Postmenopausal Osteoporosis: Review and Italian Experience 95
Osteoporosi e malattie reumatiche: nuove opportunità terapeutiche. Up-to-date 2008 92
Personalization of biologic therapy in patients with rheumatoid arthritis: Less frequently accounted choice-driving variables 92
Effetti scheletrici ed extrascheletrici della vitamina D 88
Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over two years 87
Bisfosfonati e osteoporosi da glucocorticoidi up-to-date 2005 87
Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men: The ESOPO study 87
Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment. (Osteoporosi da glucocorticoidi e malattie reumatiche. Patogenesi, prevenzione e trattamento) 86
Reduced bone mass and normal calcium metabolism in patients with systemic sclerosis 80
Efficacy of ibandronate: a long term confirmation 80
La vitamina D attraverso un secolo 78
Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description 78
Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate 78
Effects of short-term, high dose, Heparin therapy on biochemical markers of bone resorption 77
Approccio diagnostico dell’osteoporosi postmenopausale 76
Risk factors for osteoporosis in female patients with systemic lupus erythematosus 76
Multicentric Castleman's disease in a patient with primary Sjögren's syndrome. 75
Ipovitaminosi D nell’anziano in Italia e la sua prevenzione 73
Glucocorticoid-induced osteoporosis: 2013 update. 73
Single infusion of neridronate (6-amino-1hydroxy-hexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthrites:Effects on disease activity and bone resorption markers 72
Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis 72
Intramuscular neridronate in postmenopausal women with low bone mineral density 72
How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study 72
Incidenza e conseguenze dell’ipovitaminosi D. Up-to-date 2007 70
Razionale delle future terapie dell’osteoporosi 67
Bisfosfonati ed effetti scheletrici degli inibitori dell’aromatasi 65
Il dolore cronico nelle malattie reumatiche. Fisiopatologia e indicazioni di terapia. 64
Fisiopatologia dell’osteoporosi da glucocorticoidi e bisfosfonati. Up-to-date 2006 63
La salute dell’osso dall’infanzia all’età adulta 62
Ibandronato : conferma dell’efficacia a lungo termine 60
Deflazacort vs. methylprednisolone in Polymyalgia Rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens 60
Study of vitamin D status of rheumatoid arthritis patients. (Studio dello stato vitaminico D in pazienti affetti da artrite reumatoide. Razionale e disegno della rilevazione cross-sectional programmata dal gruppo SIR per lo studio dell’osteoporosi e delle malattie metaboliche dello scheletro) 58
Risedronato e trattamento dell’osteoporosi 57
Bioelectrical impedance analysis (BIA) is a reliable method to evaluate lean body mass in maintenance hemodialysis patients: comparison with dual-energy emission x-rays absorptiometry (DXA). 57
Epidemiologia dell’osteoporosi da glucocorticoidi 56
Long-term prospective study of osteoporotic pacients treated with percutaneous vertebroplasty after fragility fractures. 56
Minor connectivitis and the mixed connective tissue disease 55
Farmaci biologici antireumatici 54
Liver involvement in essential mixed cryoglobulinemia. 54
Prevenzione e trattamento dell’osteoporosi indotta da glucocorticoidi nella realtà italiana e in quella internazionale. Rassegna 53
Il risedronato 52
Terapia dell’osteoporosi. Presente e futuro 52
L’osteoporosi nelle malattie reumatiche 52
Nuove opportunità di prevenzione e trattamento del’osteoporosi indotta da glucocorticoidi 51
Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study 51
Eventi avversi dei bisfosfonati 50
Nuove frontiere farmacologiche: l’osteoporosi 48
Methotrexate and bone mass 48
Osteoporosi : i farmaci efficaci per combatterla ci sono ma vanno presi e presi correttamente! 47
Osteoporosi e malattie reumatiche: terapie di fondo 46
High rate of vertebral refracture after vertebroplasty in patients taking glucocorticoids: a prospective two-year study 45
I percorsi diagnostico-terapeutici assistenziali nella gestione del paziente con frattura. 43
L’osteoporosi nelle malattie reumatiche 41
Osteociti e vascolarizzazione ossea nella fragilità scheletrica indotta da glucocorticoidi. 41
Effetti scheletrici della vitamina D 40
Influenza sulla funzione cartilaginea e sulle malattie degenerative articolari delle adipochine 38
Osteoporosi : terapie a confronto. Introduzione 37
Meccanismi di rimodellamento osseo nelle malattie reumatiche 35
Gli effetti avversi della terapia dell’osteoporosi 35
Prevenzione e trattamento dell’osteoporosi indotta da glucocorticoidi: recenti evidenze 34
Sistema nervoso autonomo e densità minerale ossea: studio dei polimorfismi dei recettori β1 e β2-adrenergici in una popolazione femminile 34
Update sull’osteoporosi cortisonica 32
Vitamina D e malattie reumatiche 29
Totale 7.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.187 192 140 24 58 105 94 128 62 128 81 151 24
2020/2021755 86 23 53 31 93 32 67 73 56 48 61 132
2021/2022808 5 74 10 71 172 109 6 43 31 9 55 223
2022/20231.254 148 110 83 124 209 187 2 81 257 5 42 6
2023/20241.190 241 169 156 101 168 159 21 32 17 9 37 80
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 7.286